[1]周淳宇 单静怡 蒋风茹 孙博云 袁建业.NLRP6炎性小体与炎症性肠病[J].陕西中医药大学学报,2024,(04):001-6.[doi:10.13424/j.cnki.jsctcm.2024.04.001]
　ZHOU Chunyu SHAN Jingyi JIANG Fengru SUN Boyun YUAN Jianye.NLRP6 Inflammasome and Inflammatory Bowel Disease[J].Journal of Shaanxi University of Traditional Chinese Medicine,2024,(04):001-6.[doi:10.13424/j.cnki.jsctcm.2024.04.001]
点击复制

NLRP6炎性小体与炎症性肠病()
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2024年04期
页码:
001-6
栏目:
出版日期:
2024-07-17

文章信息/Info

Title:
NLRP6 Inflammasome and Inflammatory Bowel Disease
文章编号:
2096-1340(2024)04-0001-06
作者:
周淳宇 单静怡 蒋风茹 孙博云 袁建业
上海中医药大学附属龙华医院/上海市中医药研究院脾胃病研究所，上海 200032
Author(s):
ZHOU Chunyu SHAN Jingyi JIANG Fengru SUN Boyun YUAN Jianye
(Longhua Hospital Affiliated to Shanghai University of Chinese Medicine/Institute of Spleen and Stomach Diseases，Shanghai Institute of Traditional Chinese Medicine，Shanghai 200032，China)
关键词:
关键词：核苷酸结合寡聚化结构域样受体蛋白6; 炎性小体; 炎症性肠病; 白介素; 肠道菌群
Keywords:
Key words： Nucleotide-binding oligomerization domain-like receptor protein 6; Inflammatory corpuscles; Inflammatory bowel disease; Interleukin; Intestinal microbiota
分类号:
R364.5
DOI:
10.13424/j.cnki.jsctcm.2024.04.001
文献标志码:
A
摘要:
摘 要：核苷酸结合寡聚化结构域样受体蛋白（Nucleotidebinding oligomerization domainlike receptor protein，NLRP）6炎性小体由NLRP6、胱天蛋白酶1和凋亡相关斑点样蛋白组成。NLRP6是构成NLRP6炎性小体的核心蛋白，其由氨基端的热蛋白结构域中间的NACHT结构域以及羧基端的富含亮氨酸的重复序列结构域构成。由于NLRP6是较新的炎性小体，其在机体病理生理中的作用的许多细节还有待确定。目前已知NLRP6炎性小体在慢性炎症、自身免疫综合征和代谢性疾病的发展过程中发挥重要作用。炎症性肠病（inflammatory bowel disease，IBD）是与免疫失调密切相关的慢性肠道炎症性疾病，当前已成为在发达国家和发展中国家中广泛存在的全球流行病，但IBD的详细发病机制还有待彻底揭示。逐渐增多的证据显示，NLRP6炎性小体与IBD发病密切相关。文章就目前相关研究进展作一综述。
Abstract:
Abstract： Nucleotide-binding oligomerization domainlike receptor protein (NLRP) 6 inflammasomes are composed of NLRP6，caspase-1，and apoptosis related spot like proteins.NLRP6 is the core protein that constitutes the NLRP6 inflammasome，consisting of the NACHT domain in the middle of the hot protein domain at the amino end and the leucine rich repetitive sequence domain at the carboxyl end.Due to NLRP6 being a relatively new inflammasome，many details of its role in the pathophysiology of the body remain to be determined.Currently，it is known that NLRP6 inflammasomes play an important role in the development of chronic inflammation，autoimmune syndrome，and metabolic diseases.Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease closely related to immune dysfunction，and has become a widely prevalent global epidemic in developed and developing countries.However，the detailed pathogenesis of IBD still needs to be thoroughly revealed.An increasing amount of evidence suggests that NLRP6 inflammasome is closely related to the onset of IBD.The article provides a review of current research progress in related fields.

参考文献/References:

［1］ISING C,VENEGAS C,ZHANG SS,et al.NLRP3 inflammasome activation drives tau pathology［J］.Nature,2019,575(7784):669-673.
［2］BOOSHEHRI LM,HOFFMAN HM.Caps and NLRP3［J］.Journal of Clinical Immunology,2019,39(3):277-286.
［3］JIANG DL,CHEN S,SUN RY,et al.The NLRP3 inflammasome:role in metabolic disorders and regulation by metabolic pathways［J］.Cancer Letters,2018,419:8-19.
［4］WLODARSKA M,THAISS CA,NOWARSKI R,et al.NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion［J］.Cell,2014,156(5):1045-1059.
［5］TREMAINE WJ.Diagnosis and treatment of indeterminate colitis［J］.Gastroenterology & Hepatology,2011,7(12):826-828.
［6］NG SC,TANG W,CHING JY,et al.Incidence and phenotype of inflammatory bowel disease based on results from the asia-pacific Crohn-s and colitis epidemiology study［J］.Gastroenterology,2013,145(1):158-165.e2.
［7］RAY G.Inflammatory bowel disease in India -Past,present and future［J］.World Journal of Gastroenterology,2016,22(36):8123-8136.
［8］KAPLAN GG.The global burden of IBD:from 2015 to 2025［J］.Nature Reviews Gastroenterology & Hepatology,2015,12(12):720-727.
［9］SMIDS C,HORJUS TALABUR HORJE CS,GROENEN MJM,et al.The value of serum antibodies in differentiating inflammatory bowel disease,predicting disease activity and disease course in the newly diagnosed patient［J］.Scandinavian Journal of Gastroenterology,2017,52(10):1104-1112.
［10］GUAN QD.A comprehensive review and update on the pathogenesis of inflammatory bowel disease［J］.Journal of Immunology Research,2019,2019:7247238.
［11］ZHANG YZ,LI YY.Inflammatory bowel disease:pathogenesis［J］.World Journal of Gastroenterology,2014,20(1):91-99.
［12］LIU TC,STAPPENBECK TS.Genetics and pathogenesis of inflammatory bowel disease［J］.Annual Review of Pathology,2016,11:127-148.
［13］ZHENG DP,KERN L,ELINAV E.The NLRP6 inflammasome［J］.Immunology,2021,162(3):281-289.
［14］TING JPY,LOVERING RC,ALNEMRI ES,et al.The NLR gene family:a standard nomenclature［J］.Immunity,2008,28(3):285-287.
［15］温哲,唐朝晖.NLRP6的研究进展［J］.中华临床医师杂志(电子版),2014,8(15):2847-2851.
［16］BRACEY NA,PLATNICH JM,LAU A,et al.Tissue-selective alternate promoters guide NLRP6 expression［J］.Life Science Alliance,2020,4(3):e202000897.
［17］JANANI C,RANJITHA KUMARI BD.PPAR gamma gene:a review［J］.Diabetes & Metabolic Syndrome,2015,9(1):46-50.
［18］KEMPSTER SL,BELTEKI G,FORHEAD AJ,et al.Developmental control of the Nlrp6 inflammasome and a substrate,IL-18,in mammalian intestine［J］.American Journal of Physiology Gastrointestinal and Liver Physiology,2011,300(2):G253-G263.
［19］WANG PH,ZHU S,YANG L,et al.Nlrp6 regulates intestinal antiviral innate immunity［J］.Science,2015,350(6262):826-830.
［20］MARTINON F,BURNS K,TSCHOPP J.The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta［J］.Molecular Cell,2002,10(2):417-426.
［21］SHEN C,LU A,XIE WJ,et al.Molecular mechanism for NLRP6 inflammasome assembly and activation［J］.Proceedings of the National Academy of Sciences of the United States of America,2019,116(6):2052-2057.
［22］MUKHERJEE S,KUMAR R,TSAKEM LENOU E,et al.Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation［J］.Nature Immunology,2020,21(6):626-635.
［23］HARA H,SEREGIN SS,YANG DH,et al.The NLRP6 inflammasome recognizes lipoteichoic acid and regulates gram-positive pathogen infection［J］.Cell,2018,175(6):1651-1664.e14.
［24］GHIMIRE L,PAUDEL S,JIN LL,et al.NLRP6 negatively regulates pulmonary host defense in Gram-positive bacterial infection through modulating neutrophil recruitment and function［J］.PLoS Pathogens,2018,14(9):e1007308.
［25］LEVY M,THAISS CA,ZEEVI D,et al.Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling［J］.Cell,2015,163(6):1428-1443.
［26］LAMKANFI M,DIXIT VM.Mechanisms and functions of inflammasomes［J］.Cell,2014,157(5):1013-1022.
［27］NISHIDA A,INOUE R,INATOMI O,et al.Gut microbiota in the pathogenesis of inflammatory bowel disease［J］.Clinical Journal of Gastroenterology,2018,11(1):1-10.
［28］LAVELLE A,SOKOL H.Gut microbiota-derived metabolites as key actors in inflammatory bowel disease［J］.Nature Reviews Gastroenterology & Hepatology,2020,17(4):223-237.
［29］ELINAV E,STROWIG T,KAU AL,et al.NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis［J］.Cell,2011,145(5):745-757.
［30］SEREGIN SS,GOLOVCHENKO N,SCHAF B,et al.NLRP6 protects Il10-/- mice from colitis by limiting colonization of Akkermansia muciniphila［J］.Cell Reports,2017,19(4):733--745.
［31］MAMANTOPOULOS M,RONCHI F,VAN HAUWERMEIREN F,et al.Nlrp6- and ASC--dependent inflammasomes do not shape the commensal gut microbiota composition［J］.Immunity,2017,47(2):339-348.e4.
［32］LEMIRE P,ROBERTSON SJ,MAUGHAN H,et al.The NLR protein NLRP6 does not impact gut microbiota composition［J］.Cell Reports,2017,21(13):3653-3661.
［33］ZHU S,DING SY,WANG PH,et al.Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells［J］.Nature,2017,546(7660):667-670.
［34］AIZAWA Y,SUTOH S,MATSUOKA M,et al.Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease［J］.Tissue Antigens,2005,65(1):88-92.
［35］RATSIMANDRESY RA,INDRAMOHAN M,DORFLEUTNER A,et al.The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway［J］.Cellular & Molecular Immunology,2017,14(1):127-142.
［36］SEREGIN SS,GOLOVCHENKO N,SCHAF B,et al.NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury［J］.Mucosal Immunology,2017,10(2):434-445.
［37］ITANI S,WATANABE T,NADATANI Y,et al.NLRP3 inflammasome has a protective effect against oxazolone-induced colitis:a possible role in ulcerative colitis［J］.Scientific Reports,2016,6:39075.
［38］MONTELEONE G,TRAPASSO F,PARRELLO T,et al.Bioactive IL-18 expression is up-regulated in Crohn’s disease［J］.Journal of Immunology,1999,163(1):143-147.
［39］YASUDA K,NAKANISHI K,TSUTSUI H.Interleukin-18 in health and disease［J］.International Journal of Molecular Sciences,2019,20(3):649.
［40］YAO XM,ZHANG CH,XING Y,et al.Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis［J］.Nature Communica-tions,2017,8:1896.
［41］吴国豪.肠道屏障功能［J］.肠外与肠内营养,2004,11(1):44-47.
［42］SHARMA D,MALIK A,GUY CS,et al.Pyrin inflammasome regulates tight junction integrity to restrict colitis and tumorigenesis［J］.Gastroenterology,2018,154(4):948-964.e8.
［43］黄艳芬,刘湘红,伍浩,等.肠黏膜屏障与肠道菌群的相互关系［J］.中国微生态学杂志,2019,31(12):1465-1469,1474.
［44］CHEN GY,LIU MC,WANG FY,et al.A functional role for Nlrp6 in intestinal inflammation and tumorigenesis［J］.Journal of Immunology,2011,186(12):7187-7194.
［45］SWIDSINSKI A,LOENING-BAUCKE V,THEISSIG F,et al.Comparative study of the intestinal mucus barrier in normal and inflamed colon［J］.Gut,2007,56(3):343-350.
［46］HU B,ELINAV E,HUBER S,et al.Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer［J］.Proceedings of the National Academy of Sciences of the United States of America,2013,110(24):9862-9867.
［47］卞莹莹,王洁,李安,等.炎症性肠病的药物治疗现状［J］.药学实践杂志,2017,35(3):197-200,228.
［48］苏晓兰,国嵩,张涛,等.炎症性肠病诊治现状及中医药治疗特色与优势［J］.北京中医药,2020,39(3):211-215.
［49］ZHANG ZC,SHEN P,XIE WB,et al.Pingwei San ameliorates dextran sulfate sodium-induced chronic colitis in mice［J］.Journal of Ethnopharmacology,2019,236:91-99.
［50］曾于恒,杨芳,何永恒.白芍七物颗粒对NLRP3炎症体介导溃疡性结肠炎调控研究［J］.时珍国医国药,2019,30(4):782-785.
［51］LIANG J,CHEN SX,CHEN JH,et al.Therapeutic roles of polysaccharides from Dendrobium Officinaleon colitis and its underlying mechanisms［J］.Carbohydrate Polymers,2018,185:159-168.
［52］GHIMIRE L,PAUDEL S,JIN LL,et al.The NLRP6 inflammasome in health and disease［J］.Mucosal Immunology,2020,13(3):388-398.
［53］ANGOSTO-BAZARRA D,MOLINA-LPEZ C,PELEGRN P.Physiological and pathophysiological functions of NLRP6:pro-and anti-inflammatory roles［J］.Communications Biology,2022,5:524.
［54］VENUPRASAD K,THEISS AL.NLRP6 in host defense and intestinal inflammation［J］.Cell Reports,2021,35(4):109043.
［55］GREMEL G,WANDERS A,CEDERNAES J,et al.The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling［J］.Journal of Gastroenterology,2015,50(1):46-57.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金项目（82104743）
更新日期/Last Update: 2024-07-11